Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,473.47
(
0.37%
)
US TECH 100
28,612.40
(
0.11%
)
Dow Jones
50,579.70
(
0.58%
)
Brent Oil
101.17
(
0.00%
)
Bitcoin
77,200.03
(
0.66%
)
News Focus
News Focus
Post# of 518749
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Investor2014

Send PM Follow Ignore
Followers 65
Posts 27891
Boards Moderated 0
Alias Born 11/23/2016

Investor2014

Re: gerry57 post# 494326

Saturday, 07/19/2025 9:52:04 AM

Saturday, July 19, 2025 9:52:04 AM

Post# of 518749
Pointing to the shortcomings of other treatments doesn’t excuse the deficiencies of an application like Anavex’s. Each submission must stand on its own merits, as we've seen with previous EMA reviews of monoclonal antibody applications.

The longer we wait, the sooner we will get rich!

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News